Suchergebnisse - "Sauter, Max"

PubPharm (106)

1

Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP)

enthalten in: International journal of molecular sciences | 2024

von Rigalli, J. | Gagliardi, A. | Diester, K. | +11

2

In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo-keto reductases

enthalten in: Archives of toxicology | 2024

von Bajraktari-Sylejmani, G. | Oster, J. | Burhenne, J. | +3

3

Effect of Tacrolimus Formulation (Prolonged-Release vs Immediate-Release) on Its Susceptibility to Drug-Drug Interactions with St. John's Wort

enthalten in: Clinical pharmacology in drug development | 2024

von Gümüs, K. | Teegelbekkers, A. | Sauter, M. | +6

4

In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo–keto reductases

enthalten in: Archives of toxicology | 2024

von Bajraktari-Sylejmani, G. | Oster, J. | Burhenne, J. | +3

5

Effect of tacrolimus formulation (prolonged-release vs immediate-release) on its susceptibility to drug-drug interactions with St. John's Wort

enthalten in: Clinical pharmacology in drug development | 04 January 2024

von Gümüs, K. | Teegelbekkers, A. | Sauter, M. | +6

6

In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo-keto reductases

enthalten in: Archives of toxicology | 4 January 2024

von Bajraktari-Sylejmani, G. | Oster, J. | Burhenne, J. | +3

7

Effect of Tacrolimus Formulation (Prolonged‐Release vs Immediate‐Release) on Its Susceptibility to Drug‐Drug Interactions with St. John's Wort

enthalten in: Clinical Pharmacology in Drug Development | 2024

von Gümüs, K. | Teegelbekkers, A. | Sauter, M. | +6

8

Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin

enthalten in: Cardiovascular drugs and therapy | 2023

von Krohmer, E. | Rohr, B. | Stoll, F. | +10

9

Bioanalysis of the Ex Vivo Labile PACE4 Inhibitory Peptide Ac-[d-Leu]LLLRVK-Amba in Whole Blood Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Quantification

enthalten in: Pharmaceutics | 2023

von Sauter, M. | Haag, J. | Bay, C. | +4

10

Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC

enthalten in: Nature cancer | 2023

von Zhou, X. | An, J. | Kurilov, R. | +23

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]